{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:07:00Z","timestamp":1787929620448,"version":"build-2784847793"},"reference-count":30,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2004,5,5]],"date-time":"2004-05-05T00:00:00Z","timestamp":1083715200000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2004,5]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To determine if finasteride can reduce symptoms in men with a clinical diagnosis of chronic nonbacterial prostatitis (National Institutes of Health, NIH, category IIIA chronic pelvic pain syndrome, CPPS) compared with placebo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PATIENTS AND METHODS<\/jats:title>\n                    <jats:p>Men (76) with category IIIA CPPS enrolled in four North American prostatitis research centres were randomized after a 2\u2010week placebo run\u2010in to finasteride or placebo for 6\u2003months. The primary efficacy variable was a subjective overall assessment (SOA); the secondary efficacy variables included the NIH chronic prostatitis symptom index (NIH\u2010CPSI) and safety data. Patients were assessed at screening, baseline (after the 2\u2010week placebo run\u2010in), 3 and 6\u2003months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Sixty\u2010four patients had at least one assessment on medication (31 placebo, 33 finasteride); 75% of the finasteride and 54% of the placebo group had at least a mild improvement (defined as &gt;\u200a25% improvement in SOA), and 44% and 27%, respectively, a moderate or marked improvement (&gt;50% improvement in SOA). The trend was similar in the NIH\u2010CPSI scores. Five patients in the finasteride and seven in the placebo group reported medication\u2010related adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>This randomized placebo\u2010controlled pilot study suggests that finasteride was of benefit for some men with category IIIA CPPS, but the results do not justify recommending finasteride as monotherapy, except for men who also have benign prostatic hyperplasia. A larger, properly powered study, possibly evaluating combination with other therapies or specifically in men with prostatitis and benign prostatic hyperplasia, is required to confirm any clinical benefit.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1464-410x.2003.04766.x","type":"journal-article","created":{"date-parts":[[2004,5,5]],"date-time":"2004-05-05T11:45:21Z","timestamp":1083757521000},"page":"991-995","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":116,"title":["A randomized placebo\u2010controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis)"],"prefix":"10.1111","volume":"93","author":[{"given":"J.C.","family":"Nickel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Downey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Pontari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.A.","family":"Shoskes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.I.","family":"Zeitlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,5,5]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-133-5-200009050-00013"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1159\/000019784"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(03)00583-1"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000117811.40279.19"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)63960-2"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(03)00466-7"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000054983.45096.16"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(99)00358-1"},{"key":"e_1_2_8_10_2","first-page":"63","article-title":"Effects of pentosan polysulfate sodium in men with chronic pelvic pain syndrome: a multi\u2010center randomized, placebo\u2010controlled study","volume":"167","author":"Nickel JC","year":"2002","journal-title":"J Urol"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(02)01601-1"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.74.3.505"},{"key":"e_1_2_8_13_2","first-page":"293","volume-title":"Prostatitis.","author":"Evans DTP","year":"1999"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365599709070335"},{"key":"e_1_2_8_15_2","unstructured":"GolioG.The use of finasteride in the treatment of chronic nonbacterial prostatitis. InAbstracts of the 49th Annual Meeting of the Northeastern Section of the AUA. Litchfield Arizona:October 2326 1997:128"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(98)00540-8"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.3.236"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(99)00205-8"},{"key":"e_1_2_8_19_2","first-page":"492","article-title":"Bacteriologic localization patterns in bacterial prostatitis and urethritis","volume":"5","author":"Meares EM","year":"1968","journal-title":"Invest Urol"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)67027-9"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)66056-7"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(03)00141-9"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)68562-X"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)64025-6"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1159\/000061406"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.1982.tb13635.x"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)65399-2"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410x.2001.02193.x"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030660"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000101487.83730.80"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030656"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1464-410X.2003.04766.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1464-410X.2003.04766.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T10:45:13Z","timestamp":1761734713000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1464-410X.2003.04766.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["10.1111\/j.1464-410X.2003.04766.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1464-410x.2003.04766.x","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"value":"1464-4096","type":"print"},{"value":"1464-410X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5]]},"assertion":[{"value":"2004-05-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}